SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced that clinical investigators from leading cancer research centers will present data from recent and on-going clinical trials of multiple Celgene products in blood cancers and solid tumors at the 44th American Society of Clinical Oncology (ASCO) Meeting in Chicago, Illinois from May 31 – June 3, 2008.
